Prognostic role of pretreatment serum α-hydroxybutyrate dehydrogenase in patients with small cell lung cancer
Elevated pretreatment serum α-HBDH is independently associated with poor OS in SCLC patients. The potential of HBDH as a complementary marker for the prediction of SCLC survival warrants further investigation in conjunction with other indicators.
Authors
- Min Liang (ORCID: https://orcid.org/0000-0002-6348-0043)
- Qizhong Xu (ORCID: https://orcid.org/0000-0001-7748-9586)
- Fan Zhang (ORCID: https://orcid.org/0000-0002-2491-3600)
- Xuewen Hou (ORCID: https://orcid.org/0000-0003-0334-8304)
Institutions
- Guangdong Medical College (CN)
- Shanxi Medical University (CN)
- Dongguan People’s Hospital (CN)
- Shanxi Provincial People’s Hospital (CN)
- Shenzhen Second People's Hospital (CN)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1186/s12890-025-03996-0
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00